| Literature DB >> 34567948 |
Takeharu Imai1, Yoshihiro Tanaka1, Hidenori Ojio1, Yuta Sato1, Tomonari Suetsugu1, Masahiro Fukada1, Itaru Yasufuku1, Yoshinori Iwata1, Hisashi Imai1, Naoki Okumura1, Nobuhisa Matsuhashi1, Takao Takahashi1, Kei Noguchi2, Tatsuhiko Miyazaki2, Kazuhiro Yoshida1.
Abstract
Cervical esophageal adenocarcinoma has a low incidence rate and its treatment involves various strategies. We report a patient with locally advanced cervical to upper esophageal adenocarcinoma who was able to undergo induction chemotherapy and radical surgery. A 55-year-old man was diagnosed with a poorly differentiated adenocarcinoma between the cervical and upper thoracic esophagus. The primary lesion had infiltrated into the tracheal membrane and had metastasized into the cervical lymph nodes. The initial diagnosis was T4bN1M1 stage IVB. The lower edge of the tumor was close to the tracheal bifurcation, making it difficult to create a longitudinal tracheal foramen during surgery. Therefore, when biweekly-DCF therapy was performed as induction chemotherapy, the tumor shrank sufficiently and its infiltration into the tracheal membrane decreased subsequently. We performed total laryngopharyngoesophagectomy with three-field lymph node dissection and reconstruction using free jejunal grafts and subtotal stomach via a posterior mediastinum route and a permanent tracheal foramen as a radical surgery. The pathological diagnosis was T2/MP, N1, and the effect of chemotherapy was grade 2. Cervical esophageal adenocarcinoma was rare, but technically reliable and safe oncologic surgery was possible after induction chemotherapy. © The Japan Society of Clinical Oncology 2021.Entities:
Keywords: Cervical esophageal adenocarcinoma; Induction chemotherapy; Total laryngopharyngoesophagectomy
Year: 2021 PMID: 34567948 PMCID: PMC8421492 DOI: 10.1007/s13691-021-00505-y
Source DB: PubMed Journal: Int Cancer Conf J ISSN: 2192-3183